De Weer, Marc Maurice Germain,Vrielynck, Sara Bertha Camiel,Sabourault, Nicolas Luc,Moeschwitzer, Jan Peter
申请号：
AU2015215044
公开号：
AU2015215044A1
申请日:
2015.02.04
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention discloses pharmaceutical compositions comprising: a compound according to Formula (I) useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
